Tirzepatide: The Next‑Generation Dual Agonist for Diabetes and Obesity
Keywords: Tirzepatide, dual GIP/GLP‑1 agonist, weight loss, type 2 diabetes, SURPASS, SURMOUNT, cardiovascular, adverse effects 1. Overview & Discovery Tirzepatide (brand names Mounjaro® for diabetes